您要查找的是不是：
- Malignant pleural mesothelioma(MPM)represents a rare disease. 恶性胸膜间皮瘤(MPM)是一种罕见的恶性肿瘤。
- Malignant pleural mesothelioma (MPM) is an uncommon, but no longer rare cancer. 摘要恶性肋膜间皮瘤是个不常见却又不再罕见的癌症。
- Pemetrexed disodium is the only agent for the treatment of malignant pleural mesothelioma(MPM). 培美曲塞二钠是唯一治疗恶性胸膜间皮瘤(MPM)的药物。
- Suspicious for malignant pleural mesothelioma patients, CT examination is most useful. 对于可疑恶性胸膜间皮瘤的病人，CT检查最为有用。
- Objective: To diagnose the malignant pleural mesothelioma using the video-assisted thoracoscope. 目的利用电视胸腔镜对恶性胸腔积液进行诊断。
- Meanwhile,the practical values of these methods in diagnosis,staging and prognosis of malignant pleural mesothelioma are investigated in this paper. 现就恶性胸膜间皮瘤的影像学表现,以及各种影像学检查方法对恶性胸膜间皮瘤诊断、分期、预后判断的价值作一综述。
- CONCLUSIONS: The presence of N2 disease negatively affects the prognosis of patients with malignant pleural mesothelioma. 结论：N2期对于恶性胸膜间皮瘤患者的预后有着负性的影响。
- CONCLUSIONS: The presence of N2 disease negatiely affects the prognosis of patients with malignant pleural mesothelioma. 结论：N2期对于恶性胸膜间皮瘤患者的预后有着负性的影响。
- METHODS: We reviewed 50 consecutive patients undergoing extrapleural pneumonectomy for malignant pleural mesothelioma in our institution between January 1993 and March 2005. 方法：我们连续回顾自1993年1月至2005年3月在共50例我科胸膜外全肺切除术的恶性胸膜间皮瘤病人。
- METHODS: We reiewed 50 consecutie patients undergoing extrapleural pneumonectomy for malignant pleural mesothelioma in our institution between January 1993 and March 2005. 方法：我们连续回顾自1993年1月至2005年3月在共50例我科胸膜外全肺切除术的恶性胸膜间皮瘤病人。
- Malignant pleural mesothelioma(MPM),originated from pleural mesotheliumcell is a highly maglinant and rare tumor with atypical manifestation and worse prognosis. 恶性胸膜间皮瘤(MPM)是起源于胸膜间皮细胞一种罕见肿瘤,该病无典型表现,恶性程度较高,预后较差。
- Pemetrexed is a multitargeted antimetabolite that has shown activity in malignant pleural mesothelioma and NSCLC,which has been approved in more than 70 countries. 培美曲塞是一种多靶点的抗代谢类药物,目前已经在70余个国家批准上市,用于治疗恶性胸膜间皮瘤和非小细胞肺癌。
- Malignant pleural mesothelioma(MPM),originated from pleural mesothelium cell,is an fatal tumor with natual history of only about several months,has showed an increased morbility recently. 恶性胸膜间皮瘤是发生于胸膜间皮细胞的恶性度较高的一种罕见肿瘤,近年来发病率逐步上升。
- Surgical therapy for malignant pleural mesothelioma 恶性胸膜间皮瘤的外科治疗
- Diffuse malignant pleural mesothelioma 弥漫性恶性胸膜间皮瘤
- Pleural mesothelioma occurs when one of the pleura in the chest cavity becomes malignant. 胸膜间质瘤胸腔的一部分胸膜恶变后。
- For the 13 patients with diffuse malignant pleural mesotheliomas, 6 patients underwent pleurectomy and chemotherapy, the mean survival time was more than 16 months. 弥漫性恶性胸膜间皮瘤13例，行胸膜剥脱术加辅助化疗6例，平均存活16个月以上；
- Diagnosis of malignant pleural mesothelioma by thoracoscopy 经电视胸腔镜确诊恶性胸膜间皮瘤
- Current status in treatment of malignant pleural mesothelioma 恶性胸膜间皮瘤的治疗现状
- Imaging Differentiation of Malignant Pleural Mesothelioma 恶性胸膜间皮瘤的影像学鉴别诊断
